相关实验视频
Updated: Jan 10, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
885
减肥新药:为什么改变身体成分很重要,为什么营养和运动仍然至关重要
1Honorary lecturer in the Department of Family Practice at the University of British Columbia in Vancouver. jbosomworth@gmail.com.
Canadian family physician Medecin de famille canadien
|November 24, 2025
概括
新的减肥药物,如semaglutide和tirzepatide对于肥胖是有效的,但需要仔细的患者选择和综合的营养/运动计划,以保持瘦身量并避免有害的体重循环.
科学领域:
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
- 运动生理学 运动生理学
背景情况:
- 肥胖是一种复杂的慢性疾病,需要有效的管理策略.
- 新兴的药物疗法为减肥提供了新的途径.
- 在减肥期间最大限度地减少瘦身量损失对于代谢健康和长期结果至关重要.
研究的目的:
- 为了指导患者选择新的减肥药物疗法.
- 确定减轻减肥期间瘦肉量损失的策略.
- 评估营养和运动与药物治疗的作用.
主要方法:
- 使用推评估,开发和评估 (GRADE) 框架对证据的评估.
- 临床试验数据的分析,以测定西马格卢提德和蒂尔泽帕提德的疗效和安全性.
- 审查关于营养和运动干预措施以保护瘦肉质量的研究.
主要成果:
- 塞马格卢提德和蒂尔泽帕提德适用于肥胖或超重并患有并发症的患者.
- 长期使用可能是必要的;在儿科患者群体中已注意到疗效,但长期影响尚不清楚.
- 蛋白质补充和抵抗训练有效地保护肌肉和骨质;有氧训练有助于预防骨质疏松症.
结论:
- 患者选择抗肥胖药物应符合临床试验标准,并包括同时进行饮食和运动干预.
- 在非常年轻或老年人群中使用需要谨慎,因为长期数据有限.
- 为轻微减肥而间歇使用可能是有害的;持续监测和数据是必不可少的.
相关概念视频
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228
Drug Dosing: Obese Patients
204
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
204
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Antidepressant Drugs: MAOIs and Other Agents
776
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
776

